Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$3.35

(0.00%)

15:59
04/12/18
04/12
15:59
04/12/18
15:59

Rigel says website corrected, FDA continuing review of fostamatinib NDA

Rigel Pharmaceuticals reported that due to an error by the external host of its investor relations website, inaccurate information was displayed regarding the U.S. Food and Drug Administration's review of the New Drug Application, or NDA, for fostamatinib for the treatment of adult patients with chronic immune thrombocytopenia. "The website has been corrected. The FDA is continuing its review of the NDA and the Prescription Drug User Fee Act action date is April 17, 2018," the company stated.

  • 17

    Apr

RIGL Rigel Pharmaceuticals
$3.35

(0.00%)

04/03/18
JEFF
04/03/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff on IgAN trial miss overdone, says Jefferies
Jefferies analyst Eun Yang called the fact that Rigel Pharmaceuticals' Phase 2 trial evaluating fostamatinib in IgAN failed to meet its primary endpoint "somewhat disappointing," but also said the news does not change his valuation or view on the approvability in patients with chronic or persistent immune thrombocytopenia. The analyst, who said the company is "completely optimistic" for timely approval of fostamatinib in the ITP indication by the PDUFA date of April 17, keeps a Buy rating and $5 price target on Rigel shares, calling today's selloff "overdone."
04/03/18
HCWC
04/03/18
NO CHANGE
Target $6.7
HCWC
Buy
H.C. Wainwright says Rigel's 'small setback' a buying opportunity ahead of PDUFA
H.C. Wainwright analyst Joseph Pantginis called news that Rigel Pharmaceuticals' Phase 2 study of fostamatinib in patients with IgA nephropathy did not meet its primary endpoint a "small setback" for the company and an opportunity for investors. He believes today's selling pressure is an overreaction, adding that "brighter skies may be tomorrow, almost literally," with the company's PDUFA date for fostamatinib in ITP coming on April 17. Pantginis reiterates a Buy rating on Rigel and trimmed his price target on the stock to $6.70 from $7.
04/04/18
JEFF
04/04/18
NO CHANGE
Target $5
JEFF
Buy
Rigel selloff yesterday on failed study overdone, says Jefferies
Jefferies analyst Eun Yang says that while yesterday's Phase 2 trial results in IgA nephropathy, fostamatinib's third indication, is "somewhat disappointing," it does not change her valuation or upcoming approvability in first indication immune thrombocytopenic purpura. The analyst views the selloff yesterday in shares of Rigel Pharmaceuticals as overdone. She believes the failed study has no bearing on the approval in ITP, which has an FDA action date of April 17. Yang reiterates a Buy rating on Rigel with a $5 price target.
04/09/18
JPMS
04/09/18
NO CHANGE
JPMS
Overweight
Rigel Pharmaceuticals shares can rally 80% on FDA approval, says JPMorgan
JPMorgan analyst Anupam Rama continues to see a favorable risk/reward profile on Rigel Pharmaceuticals heading into the April 17 FDA action date for Tavalisse in immune thrombocytopenia. The analyst sees a "high probability" of approval for Tavalisse and 50%-80% share upside on the news, "assuming no major surprises in the label." The approval is setting up to be a "true binary event," with potential share downside in the 65%-80% range, Rama tells investors in a research note. He keeps an Overweight rating on Rigel shares.

TODAY'S FREE FLY STORIES

ANAB

AnaptysBio

$68.73

0.8 (1.18%)

09:32
11/21/18
11/21
09:32
11/21/18
09:32
Initiation
AnaptysBio initiated  »

JPMorgan sees attractive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Recommendations
Foot Locker, Nike analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CS

Credit Suisse

$11.72

-0.585 (-4.75%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Downgrade
Credit Suisse rating change  »

Credit Suisse downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

09:30
11/21/18
11/21
09:30
11/21/18
09:30
General news
The U.S. durables report undershot estimates »

The U.S. durables report…

GPS

Gap

$24.65

-0.79 (-3.11%)

09:26
11/21/18
11/21
09:26
11/21/18
09:26
Recommendations
Gap analyst commentary  »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ADI

Analog Devices

$89.12

3.57 (4.17%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

, S

Sprint

$6.08

-0.11 (-1.78%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Periodicals
T-Mobile shifts approach to selling Sprint merger to regulators, Bloomberg says »

T-Mobile (TMUS), in a…

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

S

Sprint

$6.08

-0.11 (-1.78%)

T

AT&T

$29.41

-0.93 (-3.07%)

VZ

Verizon

$59.46

-1.17 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

QCOM

Qualcomm

$54.92

0.02 (0.04%)

, AAPL

Apple

$177.10

-8.7 (-4.68%)

09:23
11/21/18
11/21
09:23
11/21/18
09:23
Periodicals
Qualcomm gets Apple's patent claims dismissed, Bloomberg reports »

Qualcomm (QCOM) won bid…

QCOM

Qualcomm

$54.92

0.02 (0.04%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:19
11/21/18
11/21
09:19
11/21/18
09:19
Recommendations
US Ecology analyst commentary  »

US Ecology price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$65.06

-7.9 (-10.83%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Feb

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Options
Overnight activity included 663 trades in SPX and 38 trades in VIX »

663 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$57.86

0.5 (0.87%)

09:16
11/21/18
11/21
09:16
11/21/18
09:16
Recommendations
Agco analyst commentary  »

William Blair keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$64.45

-6.3 (-8.90%)

09:15
11/21/18
11/21
09:15
11/21/18
09:15
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:11
11/21/18
11/21
09:11
11/21/18
09:11
Hot Stocks
US Ecology sees FY18 at lower end of prior guidance after Grand View explosion »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$12.75

(0.00%)

09:09
11/21/18
11/21
09:09
11/21/18
09:09
Hot Stocks
Breaking Hot Stocks news story on Zoe's Kitchen »

Zoes Kitchen trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$26.11

-0.27 (-1.02%)

09:05
11/21/18
11/21
09:05
11/21/18
09:05
Recommendations
Americold Realty Trust analyst commentary  »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
11/21/18
11/21
09:05
11/21/18
09:05
General news
Treasury Action: Treasury yields have slipped from earlier highs »

Treasury Action: Treasury…

TGP

Teekay LNG

$12.79

-0.77 (-5.68%)

09:04
11/21/18
11/21
09:04
11/21/18
09:04
Recommendations
Teekay LNG analyst commentary  »

Teekay LNG price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$149.14

0.46 (0.31%)

09:02
11/21/18
11/21
09:02
11/21/18
09:02
Hot Stocks
Ligand announces OmniAb partnership with iMetabolic Biopharma »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

DE

Deere

$138.49

-4.04 (-2.83%)

, AGCO

Agco

$57.86

0.5 (0.87%)

09:01
11/21/18
11/21
09:01
11/21/18
09:01
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Amazon (AMZN), up…

DE

Deere

$138.49

-4.04 (-2.83%)

AGCO

Agco

$57.86

0.5 (0.87%)

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

FB

Facebook

$132.47

0.85 (0.65%)

FL

Foot Locker

$46.10

-2.69 (-5.51%)

GPS

Gap

$24.65

-0.79 (-3.11%)

ABIL

Ability

$2.83

-0.15 (-5.03%)

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

BZUN

Baozun

$30.07

-0.98 (-3.16%)

BILI

Bilibili

$13.61

0.575 (4.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

09:00
11/21/18
11/21
09:00
11/21/18
09:00
General news
U.S. equities rebounded from correction lows »

U.S. equities rebounded…

TSM

TSMC

$35.64

-0.41 (-1.14%)

, INTC

Intel

$47.38

-0.61 (-1.27%)

08:57
11/21/18
11/21
08:57
11/21/18
08:57
Periodicals
TSMC set to win 'major coup' with IBM server chip deal, Nikkei says »

Well-placed supply chain…

TSM

TSMC

$35.64

-0.41 (-1.14%)

INTC

Intel

$47.38

-0.61 (-1.27%)

IBM

IBM

$117.17

-3.2 (-2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 03

    Mar

TJX

TJX

$46.81

-2.16 (-4.41%)

, BURL

Burlington Stores

$148.36

-8.145 (-5.20%)

08:56
11/21/18
11/21
08:56
11/21/18
08:56
Recommendations
TJX, Burlington Stores analyst commentary  »

TJX apparel category…

TJX

TJX

$46.81

-2.16 (-4.41%)

BURL

Burlington Stores

$148.36

-8.145 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

08:55
11/21/18
11/21
08:55
11/21/18
08:55
Technical Analysis
Technical Take: Deere falls after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

AAPL

Apple

$177.10

-8.7 (-4.68%)

, BAC

Bank of America

$27.39

-0.375 (-1.35%)

08:55
11/21/18
11/21
08:55
11/21/18
08:55
Options
Notable open interest changes for November 21st »

Tuesday's total…

AAPL

Apple

$177.10

-8.7 (-4.68%)

BAC

Bank of America

$27.39

-0.375 (-1.35%)

GE

General Electric

$7.67

-0.165 (-2.11%)

NVDA

Nvidia

$149.14

4.48 (3.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

  • 12

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.